Asthma News
-
Showcase
AioCare system could be successfully applied in primary healthcare Centers.
The role of spirometry in diagnosing and monitoring chronic obstructive airway diseases is crucial. According to WHO, the demonstration of irreversible airway obstruction is essential for diagnosing chronic obstructive pulmonary disease (COPD), which is the third leading cause of death worldwide. It is estimated that up to 67–81% of patients with COPD remain undiagnosed. Mobile phone-linked ...
By AioCare
-
Showcase
Are the patients able to perform the home spirometry with AioCare?
The Journal of Asthma published the results of a study that assessed asthma patients and their ability to perform high-quality daily spirometry with the AioCare system. The study has shown that home spirometry is safe without supervision and feasible for asthma patients. Abstract: Background: Self-management is an appealing strategy for the prevention of asthma exacerbations. This study aimed ...
By AioCare
-
Aspergillus Infection Risks in Hospitals, Homes and Buildings
Aspergillosis is a potentially life-threatening condition caused by a fungal pathogen known as Aspergillus. It is a common type of mold found outdoors and in indoor environments. It can be found at excessive concentrations indoors when buildings suffer water damage or elevated humidity levels. Fortunately, most healthy people breathe Aspergillus spores without infection concerns. However, some ...
-
Research on Safe Nebulizer Inhalation Therapy Using Clean Booth and Particle Counters
Particles Plus® instruments have once again been used by scientists for research into Nebulizer Inhalation Therapy. To test the administration of safe Nebulizer Inhalation Therapy, researchers monitored particle concentrations for different particle sizes with Particles Plus® Optical Particle Counters (OPC). Optical Particle Counters can measure particle size distribution and particle ...
-
Protecting the Immunocompromised from Invasive Mold Infection Risks in Hospitals and Buildings throughout Puerto Rico
Anyone with a weakened or suppressed immune system could be at heightened risk of developing an invasive mold infection. The Centers for Disease Control and Prevention (CDC) warns that these types of infections can occur days to weeks after exposure to fungi that live in the environment. The agency goes so far as to advise physicians to keep invasive mold infections in mind when treating people ...
-
Vitalograph Partners with NIOX to offer FeNO
Vitalograph is proud to announce that it a FeNO by NIOX® UK channel partner. Spirometry and FeNO present physicians with complementary diagnostic data to inform asthma care pathways. NIOX VERO® is non-invasive, simple-to-use, and provides rapid standardised FeNO measurements. It is a point-of-care device for assessing airway inflammation in patients with respiratory problems. With over ...
-
Vitalograph and MedM Enhance Remote Respiratory Monitoring
Vitalograph has joined forces with MedM Inc. to further enhance patient respiratory monitoring experience with digital health capabilities. The MedM health monitoring app is paired with Vitalograph’s Asthma-1 BT and Lung Monitor BT Smart devices. The app works as a digital asthma or lung function diary, helping users to better understand and manage their condition. Patient diaries like ...
-
Mitigating Aspergillus Infection Risks in Hospitals and Buildings across Puerto Rico
A potentially life-threatening condition known as aspergillosis is caused by a fungal pathogen named Aspergillus. It is a common type mold that can often be found outdoors and in indoor environments that have suffered water damage or elevated humidity levels. Fortunately, most healthy people breathe Aspergillus spores without infection concerns. However, some species are known to be a serious ...
-
Vitalograph introduces tremoflo C-100 oscillometer to its extensive range of respiratory diagnostic solutions
Vitalograph, a global leader in the development and production of respiratory diagnostic solutions and clinical trial services, has launched the Vitalograph tremoflo® C-100 at this year’s ATS International Conference, in Washington. Developed in partnership with Thorasys, the Vitalograph tremoflo® C-100 oscillometer helps to detect the presence of small airway impairment, providing ...
-
Vitalograph introduces tremoflo C-100 oscillometer to its extensive range of respiratory diagnostic solutions
Vitalograph, a global leader in the development and production of respiratory diagnostic solutions and clinical trial services, has launched the Vitalograph tremoflo® C-100 at this year’s ATS International Conference, taking place in Washington. ...
-
Protecting Building Occupants and Workers from Mold and Other Common Asthma Triggers
Throughout the United States, asthma caused 5.8 million physician office visits and 1.6 million emergency department visits as recently as 2021. Tragically, there were also 4,145 deaths due to asthma the year before. These figures point to the toll that asthma has on individuals and families, as well as lost time in classrooms, decreased productivity in the workplace, and the tremendous medical ...
-
Protecting Building Occupants and Workers from Exposure to Mold and Other Common Asthma Triggers
Throughout the United States, asthma caused 5.8 million physician office visits and 1.6 million emergency department visits as recently as 2021. Tragically, there were also 4,145 deaths due to asthma the year before. These figures point to the toll asthma has on individuals and families, as well as lost time in classrooms, decreased productivity in the workplace and the tremendous medical costs ...
-
Mold is a Common Asthma Trigger in Puerto Rico and Resources to Mitigate Exposure Risks
There are many known asthma triggers, but one of the more common ones is exposure to elevated levels of mold. This information is important for asthmatics, especially those living in Puerto Rico which has some of the highest asthma rates in the United States. Across the entire country, asthma caused 5.8 million physician office visits and 1.6 million emergency department visits as recently as ...
-
Mold as a Common Asthma Trigger Discussed in New Online Video
The IAQ Video Network and Cochrane & Associates announced the release of their latest educational video today. Their newest production discusses mold as a common asthma trigger and potential exposure risks in homes, schools and work environments. “8% of adults and 6.5% of children have asthma according to the Centers for Disease Control and Prevention,” said Paul Cochrane, ...
-
Alfa Chemistry Newly Releases Phospholipids, Modified Lipids, and Functionalized Lipids
Lipids are essential to many body functions and serve as the building blocks for living cells. Alfa Chemistry has been an ISO 9001:2015 certified supplier of nearly all forms of lipids and fatty acids and continues to broaden its product lines by adding phospholipids, modified lipids, and functionalized lipids. These lipid molecules are recently added to the already well-established collection of ...
-
Alex MacKerell, PhD, SilcsBio Co-founder & CSO, Co-Leads Study on Use of SILCS Technology to Improve Lung Disease Treatments
December 14, 2022, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced its Co-Founder and Chief Scientific Officer, Alexander D. MacKerell Jr., PhD, has co-led a study focusing on improving respiratory treatments via SilcsBio’s Site Identification by Ligand Competitive Saturation (SILCS) ...
-
Simeox device is now available in Canada!
We are happy to announce that the #simeox device is now commercially available in Canada. Proud to partner with Novus Medical to help respiratory clinicians improve the life of their patients through access to Simeox. The Simeox device is an efficient and comfortable therapy for distal mucus clearance – for patients suffering from chronic lung conditions associated with chest congestion, ...
By PhysioAssist
-
VIDA receives 510(k) clearance for deep learning-based enhancements to its LungPrint solution
VIDA Diagnostics, Inc. (“VIDA”), the leader in lung and respiratory intelligence, announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for enhancements to its LungPrint solution, including automated deep learning-based lung and lobe segmentation algorithms. This clearance further validates the quality and clinical efficacy of the ...
-
Children’s Health Month and Identifying Indoor and Outdoor Exposure Risks
October is recognized as Children’s Health Month by the U.S. Environmental Protection Agency (EPA), Centers for Disease Control and Prevention (CDC), and other agencies and organizations. CDC reports that from their earliest stages of development through puberty, children are particularly vulnerable to exposure to environmental contaminants because their bodies are small and still ...
-
Fluidda and Aptar Pharma Exclusive Collaboration
Fluidda, leader in the field of Functional Respiratory Imaging and developer of the medical device Broncholab®, today announced an exclusive collaboration with Nanopharm, an Aptar Pharma company and a leader in contract research and development services for orally inhaled and nasal drug products (OINDPs). The companies will leverage their respective proprietary technology platforms to help ...
By Fluidda
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you